Skip to content

Head to head

Eternity vs Q-Plus C EVO (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview
Purchase cost
Catalog new-price ranges: Eternity, $60k–$80k; Q-Plus C EVO, $80k–$110k. Check the source notes and request current quotes.
FDA status
No US 510(k) clearance has been located for the Eternity. Q-Plus C EVO holds FDA 510(k) clearance for its marketed indication.
Technology
Eternity: Q-switched. Q-Plus C EVO: Nd:YAG.
Practice fit
Both are listed under q-switched tattoo/pigment. Check each model’s US regulatory status and labeled indications for your intended use.

Q-Switched Tattoo/Pigment

View full device profile →

Q-Switched Tattoo/Pigment

View full device profile →

Price comparison

New price range

Astanza Eternity
$60k–$80kSource not documented
Quanta System Q-Plus C EVO
$80k–$110kSource not documented

Used asking range

Astanza Eternity
$30k–$45kSource not documented
Quanta System Q-Plus C EVO
$45k–$70kSource not documented

Payback calculator

Astanza Eternity
View ROI calculator
Quanta System Q-Plus C EVO
View ROI calculator

Next step

Astanza Eternity
Quanta System Q-Plus C EVO

Consumable economics

Consumable cost / lock-in

Astanza Eternity
Quanta System Q-Plus C EVO

Service cost

Astanza Eternity
Not published
Quanta System Q-Plus C EVO
Not published

FDA clearance

FDA status & indication

Astanza Eternity
No US 510(k) located
Quanta System Q-Plus C EVO
FDA ClearedK152012, K160368, K192160
Read FDA indication wording
The EVO Platform is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 & 532 nm (Q-Switched, nanosecond mode) The EVO Platform is intended for treatment of vascular lesions, pigmented lesions, and for hair, tattoo removal and the incision, excision, ablation, vaporization of soft tissue for General dermatology such as, but not limited to treatment of: 532 nm (Q-Switched, nanosecond mode) Removal of light ink (red, sky blue, green, tan, purple, and orange) tattoos Treatment of vascular lesions including, but not limited to: - port wine birthmarks - telangiectasias - spider angiomaa - Cherry angioma - Spider nevi Treatment of benign pigmented lesions including, but not limited to: - cafe-au-Iait birthmarks - Ephalides, solar lentigines - senile lentigines - Becker's nevi - freckles - common nevi - nevus spilus - Ota Nevus Treatment of seborrheic keratosis Treatment of post inflammatory hyperpigmentation Skin resurfacing procedures for the treatment of acne scars and wrinkles.

Which chains run each

Chain adoption

Astanza Eternity
0 recorded pairings
Quanta System Q-Plus C EVO
0 recorded pairings

Chains using it

Astanza Eternity
Quanta System Q-Plus C EVO

Approved reviews

Astanza Eternity
0
Quanta System Q-Plus C EVO
0

Specs and platform

Manufacturer

Astanza Eternity
Astanza
Quanta System Q-Plus C EVO
Quanta System

Built by (OEM)

Astanza Eternity
Astanza Laser LLC
Quanta System Q-Plus C EVO
Quanta System S.p.A.

Category

Astanza Eternity
Q-Switched Tattoo/Pigment
Quanta System Q-Plus C EVO
Q-Switched Tattoo/Pigment

Technology

Astanza Eternity
QS ruby 694nm (Q-switched)
Quanta System Q-Plus C EVO
QS Nd:YAG + ruby (+alex option) (Nd:YAG)

Launch year

Astanza Eternity
2015
Quanta System Q-Plus C EVO
2019

Status

Astanza Eternity
Current
Quanta System Q-Plus C EVO
Current

Manufacturer source record

Astanza Eternity
No linked source on file.
Quanta System Q-Plus C EVO
No linked source on file.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.